Dexamethasone combined with abiraterone acetate might result in improved survival in the treatment of castration-resistant prostate cancer compared with the Food and Drug Administration-approved prednisone combination, but the hypothesis must be confirmed with with clinical studies comparing the two combinations.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425393 | PMC |
| http://dx.doi.org/10.1634/theoncologist.2015-0010 | DOI Listing |
Publication Analysis
Top Keywords
reply dexamethasone
4
dexamethasone combined
4
combined abiraterone
4
abiraterone acetate
4
acetate result
4
result improved
4
improved survival
4
survival treatment
4
treatment castration-resistant
4
castration-resistant prostate
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!